Lantern Pharma Inc. (LTRN) Earnings History
Annual and quarterly earnings data from 2018 to 2024
Loading earnings history...
LTRN EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
LTRN Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export LTRN earnings history in CSV or JSON format
Free sign-in required to download data
Lantern Pharma Inc. (LTRN) Earnings Overview
As of May 8, 2026, Lantern Pharma Inc. (LTRN) reported trailing twelve-month net income of -$19M, reflecting -131255.1% year-over-year growth. The company earned $-1.75 per diluted share over the past four quarters.
Looking at the long-term picture, LTRN's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2018.
Lantern Pharma Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ONCO (-$14M net income, -1721.0% margin), CASI (-$49M net income, -137.6% margin), ALDX (-$43M net income), LTRN has comparable earnings metrics. Compare LTRN vs ONCO →
LTRN Earnings vs Peers
Earnings metrics vs comparable public companies
LTRN Historical Earnings Data (2018–2024)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$21M | -30.2% | -$22M | $-1930.92 | - | - |
| 2023 | -$16M | -11.9% | -$18M | $-1.47 | - | - |
| 2022 | -$14M | -15.3% | -$14M | $-1.31 | - | - |
| 2021 | -$12M | -109.3% | -$13M | $-1.13 | - | - |
| 2020 | -$6M | -143.3% | -$6M | $-0.95 | - | - |
| 2019 | -$2M | -40.6% | -$2M | $-0.39 | - | - |
| 2018 | -$2M | - | -$2M | $-0.28 | - | - |
See LTRN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LTRN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LTRN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLTRN — Frequently Asked Questions
Quick answers to the most common questions about buying LTRN stock.
Is LTRN growing earnings?
LTRN EPS fell to $-1.75, with earnings declining -131255.1%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-19M.
What are LTRN's profit margins?
Lantern Pharma Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are LTRN's earnings?
LTRN earnings data spans 2018-2024. The declining earnings trend is -131255.1% YoY. Historical data enables comparison across business cycles.